REVIEW article

Front. Nutr., 20 April 2016

Sec. Clinical Nutrition

Volume 3 - 2016 | https://doi.org/10.3389/fnut.2016.00011

Consumption of Substances of Abuse during Pregnancy Increases Consumption in Offspring: Possible Underlying Mechanisms

  • Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, NY, USA

Abstract

Correlative human observational studies on substances of abuse have been highly dependent on the use of rodent models to determine the neuronal and molecular mechanisms that control behavioral outcomes. This is particularly true for gestational exposure to non-illicit substances of abuse, such as excessive dietary fat, ethanol, and nicotine, which are commonly consumed in our society. Exposure to these substances during the prenatal period has been shown in offspring to increase their intake of these substances, induce other behavioral changes, and affect neurochemical systems in several brain areas that are known to control behavior. More importantly, emerging studies are linking the function of the immune system to these neurochemicals and ingestion of these abused substances. This review article will summarize the prenatal rodent models used to study developmental changes in offspring caused by prenatal exposure to dietary fat, ethanol, or nicotine. We will discuss the various techniques used for the administration of these substances into rodents and summarize the published outcomes induced by prenatal exposure to these substances. Finally, this review will cover some of the recent evidence for the role of immune factors in causing these behavioral and neuronal changes.

Introduction

Scientific research has relied heavily on the use of animal models to identify various characteristics of diseases and disorders found in humans. These animal models serve an important purpose when there is limited ability to ethically evaluate such disorders in humans. Most limiting in human research are studies of embryonic development and the effects produced by exposure to substances of abuse, such as alcohol, nicotine, and dietary fat, which occur as a result of voluntary maternal consumption. In humans, ingestion of alcohol during pregnancy triggers neurological disorders and increases the risk of fetal alcohol syndrome in the offspring (1, 2), effects subsequently confirmed and characterized using animal models (3–5). Also, smoking during pregnancy increases the risk of a decrease in birth weight (6, 7) and multiple behavioral problems (8), including attention deficit disorders (9) and increased propensity to abuse drugs (10, 11). In human observational studies, increased intake of dietary fats and obesity during pregnancy are found to increase the risk for dietary obesity in offspring (12–14).

Further testing of these physiological and behavioral changes using animal models exposed to substances of abuse have revealed disturbances in the development of neuronal circuits that modulate both homeostatic and reward pathways (15–17). The main players involved include a variety of neuropeptides that are found in various regions of the hypothalamus and forebrain and are shown to modulate neuronal function that may ultimately contribute to the behavioral changes in offspring. These behavioral changes include an increased propensity to ingest these substances of abuse (15–18), with a significant crossover effect from one substance to another (19). Although great strides have been taken to characterize these changes in neurochemical systems that control behavior, the molecular mechanisms involved in producing these disturbances in the brain have yet to be determined.

In addition to these neurochemicals, the field of ingestive behavior has recently focused attention on immunology. These new studies build on prior research of neurological disorders and neurodegenerative diseases, which show the immune system to play a large part in the health, function, and development of neurons and other cell types in the central nervous system (20–24), along with the development of embryos (25, 26). Recently, both human and animal observational studies have demonstrated that exposure to these substances of abuse, in addition to altering classical neuropeptide and neurotransmitter systems, also disturbs inflammatory systems in key regions of the brain that control ingestion and related behaviors (17, 27, 28). Prenatal inflammation itself has been shown to increase the risk of developing neurological disorders and diseases, such as autism (29, 30) and other psychiatric disorders (31), which the offspring are at a higher risk of developing when exposed during gestation to substances of abuse (32–35).

To understand these neurochemical and immune systems affected by prenatal substance exposure and their possible role in promoting consummatory and other behaviors in the offspring, the use of animal models involving prenatal manipulations is clearly essential. This review will cover the current techniques used to perform prenatal studies using rodent models and their general conclusions about the neuronal changes induced by embryonic exposure to environmental substances. It will also summarize the current research linking these neuronal and neurochemical changes to inflammatory systems, focusing on the three most commonly abused substances, dietary fat, alcohol, and nicotine.

Experimental Methods Used to Introduce Environmental Factors into Pregnant Rats

There are a few factors that must be taken into consideration when designing an experiment using a rodent model. The first is to choose the appropriate rodent strain to use in your model, with various strains having different preferences for different substances. Rat strains with a preference for dietary fats include Sprague-Dawley (36), Brattleboro (37, 38), and Zucker (39), with the latter having an obese phenotype. In alcohol studies, several different strains are used, including outbred rats such as Wistar (40) and Long-Evans (41), and also genetically modified rats that have increased alcohol intake, such as ALKO alcohol (42), high alcohol drinking or HAD (40), and Sardinian preferring (sP) (43) rats. In nicotine research, rats have been found to show differences in behavioral effects between different strains (44, 45) that are attributed to genetic variability. Some of the rat strains used in nicotine studies include Sprague-Dawley (46), Long-Evans (47), Lewis (48), Holtzman (49, 50), and Wistar (51).

The second factor is choosing the method for administering the substance of abuse. This can be broken down into two main paradigms, forced or choice. The forced paradigm does not give the animal a choice in intake, with the substance being the only option or its administration being forced. This is in contrast to a choice paradigm, whereby the animal has one or more competing substances to choose from, with one of the options generally being a control substance, such as chow or water. Studies on dietary fat have used both choice and forced paradigms, with some reports using a combination of the two. Generally, a high-fat and a low-fat diet are made available to the rat, with intake measured daily (52, 53). In combination paradigms, rats are exposed to the high-fat diet in conjunction with their usual diet for a period of several days until acclimation to the new diet is achieved, after which the high-fat diet is given as the only choice (52, 53). Under forced conditions, rats may be given an oil emulsion via oral gavage (54). Studies of ethanol and nicotine, in choice paradigms have used both methods of self-administration (55, 56) and two bottle conditions (57–59). Generally, the concentration of ethanol or nicotine is given in intervals, ranging from a low to high concentration, until the desired concentration is reached (60, 61), with some groups combining palatable sucrose with ethanol or nicotine until voluntary drinking of the drug is established (62). Forced exposure methods, in contrast, include oral gavage, direct injection into the peritoneal cavity (61, 63), intravenous infusion (64), a liquid diet (65), or having the substance as a sole liquid source (66–69).

In studies relating inflammation to ingestive behavior, a specific inflammatory mediator or an agent that induces inflammation, such as lipopolysaccharide, can be administered to any area of the rat through injection. This includes systemic infusion (70), intraperitoneal injection (71, 72), or use of an osmotic mini-pump (73–75).

These methods are only a brief summary, with a wide range of models and rodents used to study the effects of prenatal exposure. Once a particular model is well established, further measurements of behavior in tissues and cells of different type can be extensively performed. The sections below will focus on our current understanding of how prenatal exposure to substances of abuse affect neuronal systems that control behavior in offspring and how the inflammatory response may be a factor in promoting those changes (Figure 1).

Figure 1

Prenatal HFD Exposure

Animal models investigating the effects of excessive HFD intake during pregnancy have revealed several changes in both the physiology and behavior of offspring. Prenatal exposure to a HFD has been shown to induce several effects in offspring. These include increased body weight, faster weight gain, and larger fat pads (15, 76–78), as well as behavioral changes that include increased ingestion (15, 52, 76), autism spectrum disorders (32, 33), depression (79), and attention hyperactive disorders (80) along with a decrease in spatial memory acquisition (78, 81). Increased understanding of the neuronal systems involved in invoking these behavioral changes is made possible by the numerous animal models used to study these phenomena. These behavioral changes have been attributed to changes in the neurochemistry of various brain regions involved in homeostatic, reward, emotional, and memory processes (Figure 2) and, more recently, to changes in inflammatory processes.

Figure 2

Prenatal HFD Exposure Alters Hypothalamic Neurocircuitry

Changes in specific brain areas caused by prenatal HFD exposure seem to control different aspects of HFD intake. The change in homeostatic processes occurs in the hypothalamus, a region important in controlling ingestive behavior. Several lines of evidence show prenatal exposure to a HFD to produce changes in both the developing embryo and in adolescent and adult offspring. These include an increase in the neurogenesis of hypothalamic orexigenic peptide neurons (15, 82), with increased synthesis of the peptides that further induce HFD intake (15). These neuropeptides include galanin and enkephalin in the medial paraventricular nucleus (15, 83), orexin and melanin-concentrating hormone in the perifornical lateral hypothalamus (15), and also ghrelin in the midbrain (84).

Prenatal HFD Exposure Alters VTA–NA System in Offspring

The centers controlling the rewarding aspects of intake consist of the ventral tegmental area (VTA) and the nucleus accumbens (NA) core and shell, which contain the dopaminergic signaling system, μ-opioid receptors, and glutamatergic inputs that are activated by rewarding substances (85, 86). Similar to drug addiction (85), prolonged intake of a HFD has been shown to block dopamine reuptake and enhance dopaminergic function (87). Similarly, exposure to this diet during the prenatal period has been found in adult offspring to increase the levels and expression of dopamine in the NA core and decrease the expression of tyrosine hydroxylase in the VTA, thus decreasing the formation of dopamine (88, 89). Reduced expression of the μ-opioid receptor (89) and increased levels of enkephalin are also found in the VTA and NA regions, with injection of an enkephalin analog into the NA shown to increase HFD intake (90, 91). Similar changes in dopamine, dopamine transporter, and μ-opioid receptor have been found in other studies using maternal junk food or obesity-prone offspring (92, 93), in addition to a reduction in dopamine release in the nucleus accumbens and other terminal sites of dopamine release (92). These studies suggest that prenatal HFD exposure markedly alters the reward pathway, inducing a compensatory mechanism that leads the offspring to ingest excessive amounts of dietary fat to obtain a rewarding feeling caused by the reduced dopamine function (88, 92). Epigenetic changes involving hypomethylation are also found for the dopamine transporter, μ-opioid receptor, and enkephalin, suggesting long-term changes and consequences in offspring (89). While studies in the VTA–NA system have mostly focused on dopamine and agonists of the μ-opioid receptor, other targets are also involved. These include ghrelin, a neuropeptide, known to stimulate the rewarding effects of food intake (94) and promote the rewarding feeling of food intake (95), which is also abundantly expressed in the VTA and found to increase HFD feeding after injection into the VTA (84).

Prenatal HFD Has Global Effects on Other Areas of the Brain in Offspring

Other brain regions also show permanent changes that affect behavior. In the hippocampus, prenatal HFD exposure in offspring decreases expression and levels of proteins that are involved in memory function, such as brain-derived neurotrophic factor, nerve growth factor, and synaptophysin, suggesting a delay in memory acquisition (78, 81). The transcription of genes controlling executive function in the prefrontal cortex is also markedly increased by dietary fat in offspring (96). The emotional aspect of feeding, controlled by the amygdala, has been found in adult rats to evoke several changes in neurochemical pathways (97, 98) that in turn may induce changes in anxiety as well as feeding. Although there are only a few studies of prenatal HFD exposure that have examined the amygdala, there is some evidence that altered functioning of this brain region is involved in emotional changes in offspring that may further promote consumption. Exposure to a fat-rich diet during the prenatal period causes in offspring an increase in corticosteroid receptors in the amygdala (99). This exposure also increases anxiety in an open field, an elevated plus maze, and during light–dark transition tasks, while increasing corticosteroid levels in response to stress (99), suggesting an overall increase in the stress response and thus anxiety. These responses have been reported to increase ingestive behavior in attempt to reduce stress (100–102). These global brain changes affecting decision-making may be involved in both the impulsive and rational choice to overeat.

Prenatal HFD Induces Epigenetic Changes in Offspring

The effect of a HFD during the prenatal period on gene expression in developing neurons is thought to be attributed to epigenetic changes. In human adults, several studies in peripheral tissue reveal alterations in histone modification at promoters of proteins that are affected by dietary fat (103) and in methylation in specific tissue such as skeletal muscle (104). Prenatal exposure to a HFD has also been shown to alter methylation or microRNA expression in placental tissue (105) and adipose tissue (106, 107). That epigenetic changes may be transmitted to offspring is indicated by studies showing a generational effect on specific genes during dietary protein restriction (108, 109). While there is little evidence on the epigenetic effects of prenatal HFD exposure in neurons of embryos and postnatal offspring, several reviews exist that describe global metabolic epigenetic changes in the periphery (110, 111), indicating the need for more such studies in the brain.

Relationship between Dietary Fat and Inflammation

While several studies examining the effects of acute and chronic inflammatory mediators in adult obese animals have revealed an increase in fat intake and weight gain (112), evidence from prenatal inflammatory studies is more limited. Early findings show chronic HFD intake to induce a systemic low-grade inflammation characterized by an increase in cytokines and chemokines (113, 114). This HFD intake also increases the activation of several inflammatory signaling pathways, such as jun amino-terminal kinases, nuclear factor kappa light-chain enhancer, inhibitor of nuclear factor kappa-B kinase subunit beta, peroxisome proliferator-activator receptor, and toll-like receptors (115–118). Chronic treatment with an agent, such as lipopolysaccharide, that induces inflammation can increase body fat mass and caloric intake, and these effects are exacerbated by a HFD (119), suggesting a strong link between HFD and inflammation. More recent studies have uncovered a major role for chemokines, specifically CCL2, which is affected by a HFD and may also mediate neuronal function. This chemokine has been found early on to be increased in obese animals and during HFD intake (120) and, along with its receptor CCR2, is found in all of the key brain areas involved in HFD ingestion (121, 122). Furthermore, blocking the CCR2 receptor with an antagonist is shown to improve symptoms of obesity and decrease food intake (123, 124). In limited studies, prenatal HFD exposure has been found to increase CCL2 in peripheral organs, such as the liver, in offspring (125).

Recent studies from our lab have found a positive relationship between CCL2 and both the migration and expression of orexigenic peptide neurons in primary hypothalamic neurons (126). Exposing cultured embryonic hypothalamic neurons to increasing levels of CCL2 revealed a dose-dependent increase in migration as well as expression of the orexigenic peptides, enkephalin, and galanin in neurons (126). These hypothalamic enkephalin-expressing neurons are found to co-express the receptor, CCR2 (Figure 3), with CCL2 treatment increasing the number of colocalized neurons (126), suggesting an important role for this chemokine in neuronal growth during the prenatal period. In addition, in rats exposed to a HFD during gestation, this chemokine system is found to be greatly altered (127). Prenatal HFD exposure decreases expression of CCL2 while increasing the expression of its receptors, CCR2 and CCR4, in the hypothalamus, and these HFD-exposed neurons are found to exhibit markedly reduced sensitivity to the actions of CCL2 on neuronal migration and peptide expression. With this limited evidence raising new but interesting questions, future studies using the prenatal HFD and prenatal inflammation models should shed light on the molecular mechanisms leading to the neuronal changes and, in turn, altering ingestive behavior in the offspring.

Figure 3

Prenatal Ethanol Exposure

Original ethanol studies have shown that exposure during the prenatal period to high levels of alcohol is associated with developing fetal alcohol spectrum disorder in offspring (1–5), with many negative developmental, behavioral, and physiological outcomes (128, 129). These high levels of alcohol, within 20–30% or 6 g/kg/day range, decrease the development of neurons in several brain areas (40, 130–132) and additionally induce epigenetic changes in fetal DNA (133–135). Currently unknown are the effects of low levels of alcohol consumption, within 5% or 1–2 g/kg/day range (16, 136–138), on fetal development and ultimately on offspring behavior. Recent studies have demonstrated that low levels of ethanol exposure during gestation induce several behavioral, neurochemical, and developmental effects, similar to prenatal HFD exposure that are caused by changes in brain regions involved in homeostasis, reward, emotional, memory, and inflammatory processes. These changes are thought to induce excessive drinking (16, 137–139), increased preference (17, 139, 140), and reinforcement (141, 142) for ethanol in offspring during the adolescent period to adulthood. These low levels have also been linked to other behavioral changes, such as hyperactivity (74). While ethanol has several targets in many brain regions, studies of low ethanol levels are lacking. This review will summarize some of the current findings in the field (Figure 4).

Figure 4

Low Levels of Ethanol Exposure Alters Hypothalamic Neurocircuitry in Offspring

In the hypothalamus, the same orexigenic neuropeptides known to stimulate HFD intake, namely enkephalin, galanin, orexin, and melanin-concentrating hormone, are also found to stimulate ethanol intake [for review, see Ref. (143); (17)]. While different neurochemical systems in the brain are known to be altered by prenatal exposure to ethanol (144–146), the stimulatory effects of prenatal ethanol on these specific neuropeptides are particularly notable, given the potency of their effects on behavior and the sensitivity of the peptide neurons to low doses of ethanol (16, 147). A study from our group has also found low levels of ethanol to increase the genesis of hypothalamic neurons containing enkephalin, orexin, galanin, and melanin-concentrating hormone (16, 17). Additionally, prenatal ethanol exposure is shown to affect stress hormones in the hypothalamus, causing in adolescent and adult offspring an increase in the expression of corticotropin-releasing factor (CRF) in the hypothalamic paraventricular nucleus (144, 148–149) along with levels of corticosterone (144) and also adrenocorticotropic hormone in this same region (144, 150). Prenatal ethanol also increases the levels of these peptides and hormones in response to stress (151–154), with increased stress linked to further consummatory behavior (155–157). Not surprisingly, the CRF system has been linked to addiction of other substances of abuse (158), including dietary fat.

Low Levels of Ethanol Exposure Alters VTA–NA Center in Offspring

Several studies have linked low levels of ethanol during the prenatal period to changes in the mesolimbic area. Increased neurogenesis of enkephalin neurons is found in the NA shell (16), with overall increased levels of enkephalin in both the VTA (159) and NA core (147, 160). These changes may significantly increase ethanol intake in offspring, as high levels of enkephalin have been shown to activate dopamine terminals in the NA (161, 162). The effects of prenatal ethanol on the dopaminergic system in these brain regions are also significant, with the VTA having an increased response to dopaminergic agonists and the NA having increased sensitivity to the stimulatory effects of alcohol in offspring (137, 163, 164). Although ghrelin has been found to be involved in the rewarding feeling of alcohol (165), there are currently no studies on how low ethanol levels during the prenatal period affects this peptide and other neurochemical systems in these brain regions of offspring.

Prenatal Ethanol Has Global Effects on Other Areas of the Brain in Offspring

While there exists plenty of research describing the effects of high gestational ethanol exposure on the developing brain, there are only a few studies measuring the effects of low ethanol exposure on other brain areas not discussed above. Some of the findings include an ethanol-induced increase in progenitor cell proliferation in the basal ganglia (166) and a decrease in neural activity in the infralimbic cortex (164). They also include increased neurogenesis in regions of the hippocampus (167). The amygdala has been suggested to be affected by low levels of ethanol during the prenatal period. Offspring exposed to low ethanol display anxiety-like behavior when exposed to stressful conditions, and this behavior has been related to both an increase in synaptic connectivity in the basolateral amygdala (168) and a decrease in GABA inhibition (169), both of which stimulate the excitability of the amygdala (168, 169). Further studies on the effects of low ethanol concentrations in these other brain regions are needed to determine the extent of ethanol’s action on neuronal development throughout the brain.

Prenatal Ethanol Induces Epigenetic Changes in Offspring

There are several studies that reveal high ethanol exposure during the prenatal period to induce dramatic epigenetic changes in offspring. The adult liver provides a clear example, with high levels of ethanol exposure found to alter DNA methylation related to alcoholic liver disease (170–172). Also, chronic maternal ethanol exposure is shown to decrease methylation at a gene called agouti viable yellow, which affects the color of their coat, that is passed down to offspring (173), while acute prenatal exposure to high levels of ethanol globally causes hypomethylation of DNA in embryos (133). Long-term prenatal exposure to high ethanol levels also induces changes in methylation and microRNA in hippocampal neurons (174). In light of these studies of high ethanol exposure, further investigations of epigenetic effects are clearly needed involving low concentrations of ethanol, which as described above have strong, stimulatory effects on neuronal development in the brain.

Relationship between Ethanol and Inflammation

Although only a few studies exist, ethanol intake has also been linked to inflammatory systems. The most commonly studied peripheral organ is the liver, with excessive drinking linked to alcoholic liver disease that increases inflammatory mediators (175, 176). More recent studies in adult animals have also shown ethanol exposure to stimulate inflammatory systems in the central nervous system. Endotoxin treatment after ethanol exposure has been found to induce a long-term inflammatory state in the brain (177) and increase nitric oxide synthase and cyclooxygenase, which lead to inflammation (178). This increase in inflammation has also been detected in offspring after prenatal exposure. Similar to prenatal HFD exposure, our lab recently found prenatal ethanol to induce several changes in the CCL2 chemokine system. We found low levels of ethanol during gestation to increase in the offspring the genesis of neurons that co-express CCR2 and melanin-concentrating hormone in the lateral hypothalamus (17), a neuropeptide implicated in excessive ethanol drinking (179). With current research showing low levels of ethanol exposure to increase drinking in offspring and produce changes in the immune system that ultimately affects neuronal function, future research on inflammatory systems could be very informative and important.

Prenatal Nicotine Exposure

The effects of prenatal nicotine exposure are broad in nature, affecting both behavioral and neuronal development in several regions of offspring brain. Human studies show that children exposed to tobacco during gestation exhibit an increased risk for tobacco use, craving, and withdrawal (180), as well as dependence (181). Animal studies similarly reveal increased nicotine self-administration and consumption in adolescent and adult offspring (182–185), along with increased ingestion of other substances including fat and ethanol (18). Additional behavioral problems include an increased risk of hyperactivity (186), impulsivity (185), and anxiety (34, 35). High levels of nicotine exposure are also associated with detrimental effects, such as growth retardation (187). While these nicotine studies lead one to question whether these changes are attributed to certain chemicals from the tobacco (188, 189) rather than to nicotine itself and result from social smoking as well as chronic smoking, the overall evidence clearly demonstrates that prenatal nicotine exposure negatively affects offspring. Similar to prenatal HFD and ethanol exposure, these changes in physiology and behavior induced by nicotine or smoking may be attributed to neuronal changes in the offspring brain (Figure 5).

Figure 5

Prenatal Nicotine Exposure Alters Hypothalamic Neurocircuitry

Similar to dietary fat and ethanol, prenatal nicotine exposure has been found to affect the neuronal architecture and function of the hypothalamus. Several neuropeptides have been found to be altered in offspring during exposure to both low and high levels of nicotine. Some of the findings include a decrease in CRF and an increase in glucocorticoid receptors in the hypothalamus (190). They also show an increase in several orexigenic peptides, including neuropeptide Y, agouti-related peptide, and proopiomelanocortin in the arcuate nucleus (191), enkephalin in the medial hypothalamic paraventricular nucleus, and orexin and melanin-concentrating hormone in the perifornical lateral hypothalamus (18, 192). One of the more important findings from our lab shows that exposure to nicotine actually stimulates the genesis of neurons that express enkephalin, orexin, and melanin-concentrating hormone in the offspring hypothalamus (18), with these peptides positively related to the intake of nicotine (193). A small number of epigenetic studies also show changes in DNA methylation of the gene encoding brain-derived neurotrophic factor in human studies (194, 195), revealing the need for further epigenetic studies of specific cell types.

Prenatal Nicotine Exposure Alters VTA–NA Center in Offspring

Prenatal nicotine exposure has been found to varying degrees to change neurons in the VTA and NA in offspring. With regards to the mesolimbic dopamine system, prenatal nicotine exposure decreases the number of dopaminergic neurons in the VTA (196), dopamine release from the NA (197, 198), and the number of dopamine binding sites in the striatum (199), altering the rewarding effects of nicotine in offspring. Neuronal connections to the VTA are also affected, with orexin innervation from the lateral hypothalamus to the VTA found to be increased (192). Additionally, prenatal nicotine reduces the number of nicotinic cholinergic receptor expression in both the VTA and NA core (196). Similar to the neurogenesis effect in the hypothalamus, prenatal nicotine increases cell survival in the NA and inhibits cell death related pathways (200), with this increase in cell survival consistent with the finding that prenatal nicotine exposure increases the nerve growth factor, BDNF (201). Further studies on this reward region in offspring will shed more light on how prenatal exposure reprograms offspring to become more prone to abusing nicotine.

Prenatal Nicotine Has Global Effects on Other Areas of the Brain in Offspring

Prenatal nicotine exposure has been found to affect several other brain regions in offspring. In the hippocampus, this exposure decreases the number of neurons (202) while increasing the number of astrocytes (202), and it also decreases the neuronal area and cell size (203, 204), suggesting decreased hippocampal function. Similar effects are also found in the cortex of early postnatal rats (205), pre-weaned rats (204), and embryos (206), with studies revealing fewer glutamatergic neurons (207). These changes in the cortex induced by prenatal exposure have been linked to cognitive deficits and impaired executive control, causing rats to be more impulsive (208). Similar to the VTA and NA, dopamine levels are also decreased in the cortex of postnatal offspring (209). In the amygdala, one study found nicotine exposure to reduce the size of the amygdala in adolescent offspring (210), while a recent study from our lab has described an increase in neurogenesis and expression of enkephalin neurons in the central amygdala (18). With nicotine intake shown to generally reduce anxiety, future studies with prenatal exposure that relate behavior to amygdaloid function in offspring, as well as to other brain regions involved in decision making, would be interesting.

Prenatal Nicotine Induces Epigenetic Changes in Offspring

Several studies show prenatal nicotine exposure to have epigenetic effects on peripheral organs in offspring. Prenatal nicotine has been found to decrease methylation on the promoter-expressing angiotensin receptor type 1a (211) and increase histone acetylation of the protein and fatty acid synthase in liver (212). Human studies have also reveal global changes in DNA methylation in offspring (213, 214). Evidence of a generational effect has also been shown in rat models, with maternal nicotine use and exposure during the prenatal period found to induce asthma and epigenetic changes in lungs of offspring that are two generations past the original exposure (215). This evidence suggests that the changes induced by prenatal nicotine exposure on brain neurochemical systems may be related to epigenetic changes occurring during development.

Relationship between Nicotine and Inflammation

While reports of pure nicotine on adult systems generally reveal a reduction in inflammation (216, 217), several studies in humans show cigarette smoking to cause an increase in inflammation (218). Also, in a rat model, exposure to pure nicotine during the gestational period is found to increase the inflammatory mediators, IL-6 and TNF-alpha, in newborn blood serum (219). While this evidence is limited, it suggests the possibility that prenatal nicotine may have similar effects to HFD and ethanol exposure on inflammatory mediators, including CCL2.

General Conclusion

The current knowledge of the neural control of ingestive behavior in offspring that are prenatally exposed to substances of abuse has come a long way from observational human studies. We are now only beginning to piece together how these changes in specific brain regions affect the overall neuronal communication within the brain. In addition, other systems of the central nervous system, such as glial cells, astrocytes, and oligodendrocytes, may also play a major role in this disturbed communication. More importantly is the emerging function of the immune system in the development of these neuronal systems in offspring and how substances of abuse disturb its actions. Future studies using these prenatal animal models will provide much insight in both the molecular and neuronal network changes as well as the mechanisms leading to these changes.

Statements

Author contributions

KP and SL prepared and revised the manuscript.

Funding

This work was supported by grants from the National Institutes of Health, F32DK100058 (KP) and R01AA12882 (SL).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    JonesKLSmithDWUllelandCNStreissguthP. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet (1973) 1:1267–71.10.1016/S0140-6736(73)91291-9

  • 2

    LemoinePHarousseauHBorteyruJPMenuetJC. Children of alcoholic parents – observed anomalies: discussion of 127 cases. Ther Drug Monit (2003) 25:132–6.10.1097/00007691-200304000-00002

  • 3

    ChernoffGF. The fetal alcohol syndrome in mice: an animal model. Teratology (1977) 15:223–9.10.1002/tera.1420150303

  • 4

    RandallCLTaylorJWalkerDW. Ethanol-induced malformations in mice. Alcohol Clin Exp Res (1977) 1:219–24.10.1111/j.1530-0277.1977.tb05876.x

  • 5

    AbelELDintcheffBA. Effects of prenatal alcohol exposure on growth and development in rats. J Pharmacol Exp Ther (1978) 207:916–21.

  • 6

    SimpsonWJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol (1957) 73:807–15.

  • 7

    ButlerNRGoldsteinHRossEM. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J (1972) 2:127–30.10.1136/bmj.2.5806.127

  • 8

    WeitzmanMGortmakerSSobolA. Maternal smoking and behavior problems of children. Pediatrics (1992) 90:342–9.

  • 9

    ThaparAFowlerTRiceFScourfieldJvan den BreeMThomasHet alMaternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry (2003) 160:1985–9.10.1176/appi.ajp.160.11.1985

  • 10

    KandelDBWuPDaviesM. Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Public Health (1994) 84:1407–13.10.2105/AJPH.84.9.1407

  • 11

    PorathAJFriedPA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol (2005) 27:267–77.10.1016/j.ntt.2004.12.003

  • 12

    EdwardsLEDickesWFAltonIRHakansonEY. Pregnancy in the massively obese: course, outcome, and obesity prognosis of the infant. Am J Obstet Gynecol (1978) 131:479–83.

  • 13

    GrossTSokolRJKingKC. Obesity in pregnancy: risks and outcome. Obstet Gynecol (1980) 56:446–50.

  • 14

    CurhanGCChertowGMWillettWCSpiegelmanDColditzGAMansonJEet alBirth weight and adult hypertension and obesity in women. Circulation (1996) 94:1310–5.10.1161/01.CIR.94.6.1310

  • 15

    ChangGQGaysinskayaVKaratayevOLeibowitzSF. Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J Neurosci (2008) 28:12107–19.10.1523/JNEUROSCI.2642-08.2008

  • 16

    ChangGQKaratayevOLiangSCBarsonJRLeibowitzSF. Prenatal ethanol exposure stimulates neurogenesis in hypothalamic and limbic peptide systems: possible mechanism for offspring ethanol overconsumption. Neuroscience (2012) 222:417–28.10.1016/j.neuroscience.2012.05.066

  • 17

    ChangGQKaratayevOLeibowitzSF. Prenatal exposure to ethanol stimulates hypothalamic CCR2 chemokine receptor system: possible relation to increased density of orexigenic peptide neurons and ethanol drinking in adolescent offspring. Neuroscience (2015) 310:163–75.10.1016/j.neuroscience.2015.09.020

  • 18

    ChangGQKaratayevOLeibowitzSF. Prenatal exposure to nicotine stimulates neurogenesis of orexigenic peptide-expressing neurons in hypothalamus and amygdala. J Neurosci (2013) 33:13600–11.10.1523/JNEUROSCI.5835-12.2013

  • 19

    ChangGQKaratayevOBarsonJRLiangSCLeibowitzSF. Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain. Neuroscience (2014) 277:665–78.10.1016/j.neuroscience.2014.07.050

  • 20

    SkrzydelskiDGuyonADaugeVRovereCApartisEKitabgiPet alThe chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem (2007) 102:1175–83.10.1111/j.1471-4159.2007.04639.x

  • 21

    GuyonAMassaFRovereCNahonJL. How cytokines can influence the brain: a role for chemokines?J Neuroimmunol (2008) 198:46–55.10.1016/j.jneuroim.2008.04.009

  • 22

    GuyonASkrzydelskiDRovereCApartisERosteneWKitabgiPet alStromal-cell-derived factor 1alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci (2008) 28:862–70.10.1111/j.1460-9568.2008.06367.x

  • 23

    ParkMHLeeYKLeeYHKimYBYunYWNamSYet alChemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation. Exp Cell Res (2009) 315:2715–26.10.1016/j.yexcr.2009.06.017

  • 24

    HinojosaAEGarcia-BuenoBLezaJCMadrigalJL. CCL2/MCP-1 modulation of microglial activation and proliferation. J Neuroinflammation (2011) 8:77.10.1186/1742-2094-8-77

  • 25

    McGrathKEKoniskiADMaltbyKMMcGannJKPalisJ. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol (1999) 213:442–56.10.1006/dbio.1999.9405

  • 26

    SaitoS. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol (2001) 52:15–33.10.1016/S0165-0378(01)00112-7

  • 27

    GraysonBELevasseurPRWilliamsSMSmithMSMarksDLGroveKL. Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology (2010) 151:1622–32.10.1210/en.2009-1019

  • 28

    LussierAAStepienKANeumannSMPavlidisPKoborMSWeinbergJ. Prenatal alcohol exposure alters steady-state and activated gene expression in the adult rat brain. Alcohol Clin Exp Res (2015) 39:251–61.10.1111/acer.12622

  • 29

    MeldrumSJStrunkTCurrieAPrescottSLSimmerKWhitehouseAJ. Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation. Front Neurosci (2013) 7:123.10.3389/fnins.2013.00123

  • 30

    Le BelleJESperryJNgoAGhochaniYLaksDRLopez-ArandaMet alMaternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells. Stem Cell Reports (2014) 3:725–34.10.1016/j.stemcr.2014.09.004

  • 31

    CannonMClarkeMCCotterDR. Priming the brain for psychosis: maternal inflammation during fetal development and the risk of later psychiatric disorder. Am J Psychiatry (2014) 171:901–5.10.1176/appi.ajp.2014.14060749

  • 32

    LeonardHNassarNBourkeJBlairEMulroySde KlerkNet alRelation between intrauterine growth and subsequent intellectual disability in a ten-year population cohort of children in Western Australia. Am J Epidemiol (2008) 167:103–11.10.1093/aje/kwm245

  • 33

    SchendelDBhasinTK. Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics (2008) 121:1155–64.10.1542/peds.2007-1049

  • 34

    EppolitoAKBachusSEMcDonaldCGMeador-WoodruffJHSmithRF. Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior. Neurotoxicol Teratol (2010) 32:336–45.10.1016/j.ntt.2009.12.009

  • 35

    ParameshwaranKBuabeidMAKaruppagounderSSUthayathasSThiruchelvamKShonesyBet alDevelopmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cell Mol Life Sci (2012) 69:829–41.10.1007/s00018-011-0805-4

  • 36

    LevinBEDunn-MeynellAABalkanBKeeseyRE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol (1997) 273:R725–30.

  • 37

    LaycockJF. Review: the Brattleboro rat with hereditary hypothalamic diabetes insipidus as an ideal experimental model. Lab Anim (1976) 10:261–70.10.1258/002367776781035332

  • 38

    OdorizziMMaxJPTankosicPBurletCBurletA. Dietary preferences of Brattleboro rats correlated with an overexpression of galanin in the hypothalamus. Eur J Neurosci (1999) 11:3005–14.10.1046/j.1460-9568.1999.00722.x

  • 39

    ClearyMPVasselliJRGreenwoodMR. Development of obesity in Zucker obese (fafa) rat in absence of hyperphagia. Am J Physiol (1980) 238:E284–92.

  • 40

    LiTKLumengLDoolittleDP. Selective breeding for alcohol preference and associated responses. Behav Genet (1993) 23:163–70.10.1007/BF01067421

  • 41

    BarsonJRFaganSEChangGQLeibowitzSF. Neurochemical heterogeneity of rats predicted by different measures to be high ethanol consumers. Alcohol Clin Exp Res (2013) 37(Suppl 1):E141–51.10.1111/j.1530-0277.2012.01858.x

  • 42

    SommerWHyytiaPKiianmaaK. The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol (2006) 11:289–309.10.1111/j.1369-1600.2006.00037.x

  • 43

    ColomboGAgabioRDiazGFaMLobinaCRealiRet alSardinian alcohol-preferring rats prefer chocolate and sucrose over ethanol. Alcohol (1997) 14:611–5.10.1016/S0741-8329(97)00075-X

  • 44

    RosecransJA. The psychopharmacological basis of nicotine’s differential effects on behavior: individual subject variability in the rat. Behav Genet (1995) 25:187–96.10.1007/BF02196927

  • 45

    ChenHHilerKATolleyEAMattaSGSharpBM. Genetic factors control nicotine self-administration in isogenic adolescent rat strains. PLoS One (2012) 7:e44234.10.1371/journal.pone.0044234

  • 46

    FudalaPJTeohKWIwamotoET. Pharmacologic characterization of nicotine-induced conditioned place preference. Pharmacol Biochem Behav (1985) 22:237–41.10.1016/0091-3057(85)90384-3

  • 47

    CorrigallWACoenKM. Fixed-interval schedules for drug self-administration in the rat. Psychopharmacology (Berl) (1989) 99:136–9.10.1007/BF00634468

  • 48

    HoranBSmithMGardnerELLeporeMAshbyCRJr. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse (1997) 26:93–4.10.1002/(SICI)1098-2396(199705)26:1<93::AID-SYN10>3.0.CO;2-W

  • 49

    JorenbyDESteinpreisREShermanJEBakerTB. Aversion instead of preference learning indicated by nicotine place conditioning in rats. Psychopharmacology (Berl) (1990) 101:533–8.10.1007/BF02244233

  • 50

    ValentineJDHokansonJSMattaSGSharpBM. Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl) (1997) 133:300–4.10.1007/s002130050405

  • 51

    LavioletteSRvan der KooyD. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry (2003) 8(50–59):59.10.1038/sj.mp.4001197

  • 52

    DourmashkinJTChangGQHillJOGaylesECFriedSKLeibowitzSF. Model for predicting and phenotyping at normal weight the long-term propensity for obesity in Sprague-Dawley rats. Physiol Behav (2006) 87:666–78.10.1016/j.physbeh.2006.01.008

  • 53

    ChangGQKaratayevOAhsanRGaysinskayaVMarwilZLeibowitzSF. Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides. Am J Physiol Endocrinol Metab (2007) 292:E561–70.10.1152/ajpendo.00087.2006

  • 54

    CarrilloCALeibowitzSFKaratayevOHoebelBG. A high-fat meal or injection of lipids stimulates ethanol intake. Alcohol (2004) 34:197–202.10.1016/j.alcohol.2004.08.009

  • 55

    HansonHMIvesterCAMortonBR. Nicotine self-administration in rats. NIDA Res Monogr (1979) 23:70–90.

  • 56

    CorcoranMELewisJFibigerHC. Forebrain noradrenaline and oral self-administration of ethanol by rats. Behav Brain Res (1983) 8:1–21.10.1016/0166-4328(83)90168-7

  • 57

    SinclairJD. Motivation for alcohol in rats: position and bottle preferences do not cause drinking. Drug Alcohol Depend (1976) 1:357–66.10.1016/0376-8716(76)90038-7

  • 58

    FlynnFWWebsterMKsirC. Chronic voluntary nicotine drinking enhances nicotine palatability in rats. Behav Neurosci (1989) 103:356–64.10.1037/0735-7044.103.2.356

  • 59

    DadmarzMVogelWH. Individual self-administration of nicotine by rats. Pharmacol Biochem Behav (2003) 76:425–32.10.1016/j.pbb.2003.08.014

  • 60

    SandbakTMurisonR. Voluntary alcohol consumption in rats: relationships to defensive burying and stress gastric erosions. Physiol Behav (1996) 59:983–9.10.1016/0031-9384(95)02173-6

  • 61

    MorgansternIChangGQBarsonJRYeZKaratayevOLeibowitzSF. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res (2010) 34:886–96.10.1111/j.1530-0277.2010.01161.x

  • 62

    SamsonHH. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res (1986) 10:436–42.10.1111/j.1530-0277.1986.tb05120.x

  • 63

    MorgansternIChangGQChenYWBarsonJRZhiyuYHoebelBGet alRole of melanin-concentrating hormone in the control of ethanol consumption: region-specific effects revealed by expression and injection studies. Physiol Behav (2010) 101:428–37.10.1016/j.physbeh.2010.07.009

  • 64

    MorgansternILukatskayaOMoonSHGuoWRShajiJKaratayevOet alStimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet. Psychopharmacology (Berl) (2013) 230:509–24.10.1007/s00213-013-3178-6

  • 65

    LumengLLiTK. The development of metabolic tolerance in the alcohol-preferring P rats: comparison of forced and free-choice drinking of ethanol. Pharmacol Biochem Behav (1986) 25:1013–20.10.1016/0091-3057(86)90079-1

  • 66

    LucchiLMorescoRMGovoniSTrabucchiM. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum. Brain Res (1988) 449:347–51.10.1016/0006-8993(88)91051-7

  • 67

    PietzakERWilcePAShanleyBC. The effect of chronic ethanol consumption on muscarinic receptors in rat brain. Neurochem Int (1988) 12:447–52.10.1016/0197-0186(88)90027-7

  • 68

    LogranoDEMatteoFTrabucchiMGovoniSCagianoRLacombaCet alEffects of chronic ethanol intake at a low dose on the rat brain dopaminergic system. Alcohol (1993) 10:45–9.10.1016/0741-8329(93)90052-P

  • 69

    Schramm-SapytaNLKingsleyMARezvaniAHPropstKSwartzwelderHSKuhnCM. Early ethanol consumption predicts relapse-like behavior in adolescent male rats. Alcohol Clin Exp Res (2008) 32:754–62.10.1111/j.1530-0277.2008.00631.x

  • 70

    LinHCWanFJKangBHWuCCTsengCJ. Systemic administration of lipopolysaccharide induces release of nitric oxide and glutamate and c-fos expression in the nucleus tractus solitarii of rats. Hypertension (1999) 33:1218–24.10.1161/01.HYP.33.5.1218

  • 71

    YoshiokaTGotoMGottschalkMEAndersonCLZellerWP. Plasma endotoxin concentration after an intraperitoneal injection of endotoxin in fed and fasted suckling rats. Shock (1994) 1:362–5.10.1097/00024382-199405000-00008

  • 72

    PorterMHHrupkaBJLanghansWSchwartzGJ. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am J Physiol (1998) 275:R384–9.

  • 73

    LindrosKOJarvelainenHA. Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy. Metab Brain Dis (2005) 20:393–8.10.1007/s11011-005-7924-2

  • 74

    KimPParkJHChoiCSChoiIJooSHKimMKet alEffects of ethanol exposure during early pregnancy in hyperactive, inattentive and impulsive behaviors and MeCP2 expression in rodent offspring. Neurochem Res (2013) 38:620–31.10.1007/s11064-012-0960-5

  • 75

    FischerCWElfvingBLundSWegenerG. Behavioral and systemic consequences of long-term inflammatory challenge. J Neuroimmunol (2015) 288:40–6.10.1016/j.jneuroim.2015.08.011

  • 76

    RothwellNJStockMJ. Body weight and brown fat activity in hyperphagic cafeteria-fed female rats and their offspring. Biol Neonate (1986) 49:284–91.10.1159/000242543

  • 77

    SalvadoJSeguesTAlemanyMArolaL. Effects of lactation on circulating plasma metabolites in ‘cafeteria-fed’ rats. Br J Nutr (1986) 55:139–47.10.1079/BJN19860017

  • 78

    PageKCJonesEKAndayEK. Maternal and postweaning high-fat diets disturb hippocampal gene expression, learning, and memory function. Am J Physiol Regul Integr Comp Physiol (2014) 306:R527–37.10.1152/ajpregu.00319.2013

  • 79

    AlatiRNajmanJMO’CallaghanMBorWWilliamsGMClavarinoA. Fetal growth and behaviour problems in early adolescence: findings from the Mater University Study of Pregnancy. Int J Epidemiol (2009) 38:1390–400.10.1093/ije/dyp252

  • 80

    RodriguezAMiettunenJHenriksenTBOlsenJObelCTaanilaAet alMaternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts. Int J Obes (Lond) (2008) 32:550–7.10.1038/sj.ijo.0803741

  • 81

    TozukaYKumonMWadaEOnoderaMMochizukiHWadaK. Maternal obesity impairs hippocampal BDNF production and spatial learning performance in young mouse offspring. Neurochem Int (2010) 57:235–47.10.1016/j.neuint.2010.05.015

  • 82

    PoonKBarsonJRFaganSELeibowitzSF. Developmental changes in embryonic hypothalamic neurons during prenatal fat exposure. Am J Physiol Endocrinol Metab (2012) 303:E432–41.10.1152/ajpendo.00238.2012

  • 83

    NaleidAMGraceMKChimukangaraMBillingtonCJLevineAS. Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding. Am J Physiol Regul Integr Comp Physiol (2007) 293:R99–105.10.1152/ajpregu.00675.2006

  • 84

    WeiXJSunBChenKLvBLuoXYanJQ. Ghrelin signaling in the ventral tegmental area mediates both reward-based feeding and fasting-induced hyperphagia on high-fat diet. Neuroscience (2015) 300:53–62.10.1016/j.neuroscience.2015.05.001

  • 85

    KoobGFNestlerEJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci (1997) 9:482–97.10.1176/jnp.9.3.482

  • 86

    BassareoVDi ChiaraG. Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci (1999) 11:4389–97.10.1046/j.1460-9568.1999.00843.x

  • 87

    ConeJJChartoffEHPotterDNEbnerSRRoitmanMF. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PLoS One (2013) 8:e58251.10.1371/journal.pone.0058251

  • 88

    NaefLSrivastavaLGrattonAHendricksonHOwensSMWalkerCD. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) (2008) 197:83–94.10.1007/s00213-007-1008-4

  • 89

    VuceticZKimmelJTotokiKHollenbeckEReyesTM. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology (2010) 151:4756–64.10.1210/en.2010-0505

  • 90

    BakshiVPKelleyAE. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes. J Pharmacol Exp Ther (1993) 265:1253–60.

  • 91

    ZhangMKelleyAE. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats. Psychopharmacology (Berl) (1997) 132:350–60.10.1007/s002130050355

  • 92

    GeigerBMBehrGGFrankLECaldera-SiuADBeinfeldMCKokkotouEGet alEvidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J (2008) 22:2740–6.10.1096/fj.08-110759

  • 93

    OngZYMuhlhauslerBS. Maternal “junk-food” feeding of rat dams alters food choices and development of the mesolimbic reward pathway in the offspring. FASEB J (2011) 25:2167–79.10.1096/fj.10-178392

  • 94

    HosodaHKojimaMKangawaK. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci (2006) 100:398–410.10.1254/jphs.CRJ06002X

  • 95

    EgeciogluEJerlhagESalomeNSkibickaKPHaageDBohloolyYMet alGhrelin increases intake of rewarding food in rodents. Addict Biol (2010) 15:304–11.10.1111/j.1369-1600.2010.00216.x

  • 96

    GrissomNMHerdtCTDesiletsJLidsky-EversonJReyesTM. Dissociable deficits of executive function caused by gestational adversity are linked to specific transcriptional changes in the prefrontal cortex. Neuropsychopharmacology (2015) 40:1353–63.10.1038/npp.2014.313

  • 97

    PrimeauxSDYorkDABrayGA. Neuropeptide Y administration into the amygdala alters high fat food intake. Peptides (2006) 27:1644–51.10.1016/j.peptides.2005.12.009

  • 98

    ChangGQKaratayevOBarsonJRChangSYLeibowitzSF. Increased enkephalin in brain of rats prone to overconsuming a fat-rich diet. Physiol Behav (2010) 101:360–9.10.1016/j.physbeh.2010.06.005

  • 99

    SasakiAde VegaWCSt-CyrSPanPMcGowanPO. Perinatal high fat diet alters glucocorticoid signaling and anxiety behavior in adulthood. Neuroscience (2013) 240:1–12.10.1016/j.neuroscience.2013.02.044

  • 100

    PrasadAPrasadC. Short-term consumption of a diet rich in fat decreases anxiety response in adult male rats. Physiol Behav (1996) 60:1039–42.10.1016/0031-9384(96)00135-7

  • 101

    KrolowRNoschangCGArcegoDAndreazzaACPeresWGoncalvesCAet alConsumption of a palatable diet by chronically stressed rats prevents effects on anxiety-like behavior but increases oxidative stress in a sex-specific manner. Appetite (2010) 55:108–16.10.1016/j.appet.2010.03.013

  • 102

    OrtolaniDOyamaLMFerrariEMMeloLLSpadari-BratfischRC. Effects of comfort food on food intake, anxiety-like behavior and the stress response in rats. Physiol Behav (2011) 103:487–92.10.1016/j.physbeh.2011.03.028

  • 103

    SuterMAMaJVuguinPMHartilKFialloAHarrisRAet alIn utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model. Am J Obstet Gynecol (2014) 210:.e1–463.10.1016/j.ajog.2014.01.045

  • 104

    JacobsenSCBronsCBork-JensenJRibel-MadsenRYangBLaraEet alEffects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia (2012) 55:3341–9.10.1007/s00125-012-2717-8

  • 105

    Gallou-KabaniCGaboryATostJKarimiMMayeurSLesageJet alSex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS One (2010) 5:e14398.10.1371/journal.pone.0014398

  • 106

    TakanabeROnoKAbeYTakayaTHorieTWadaHet alUp-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun (2008) 376:728–32.10.1016/j.bbrc.2008.09.050

  • 107

    MasuyamaHHiramatsuY. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology (2012) 153:2823–30.10.1210/en.2011-2161

  • 108

    BurdgeGCSlater-JefferiesJTorrensCPhillipsESHansonMALillycropKA. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br J Nutr (2007) 97:435–9.10.1017/S0007114507352392

  • 109

    LillycropKASlater-JefferiesJLHansonMAGodfreyKMJacksonAABurdgeGC. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr (2007) 97:1064–73.10.1017/S000711450769196X

  • 110

    MartinezJAMilagroFIClaycombeKJSchalinskeKL. Epigenetics in adipose tissue, obesity, weight loss, and diabetes. Adv Nutr (2014) 5:71–81.10.3945/an.113.004705

  • 111

    ChangoAPogribnyIP. Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome. Nutrients (2015) 7:2748–70.10.3390/nu7042748

  • 112

    IwasaTMatsuzakiTKinouchiRFujisawaSMurakamiMKiyokawaMet alNeonatal LPS injection alters the body weight regulation systems of rats under non-stress and immune stress conditions. Int J Dev Neurosci (2010) 28:119–24.10.1016/j.ijdevneu.2009.08.015

  • 113

    ParkHSParkJYYuR. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract (2005) 69:29–35.10.1016/j.diabres.2004.11.007

  • 114

    HotamisligilGS. Inflammation and metabolic disorders. Nature (2006) 444:860–7.10.1038/nature05485

  • 115

    HirosumiJTuncmanGChangLGorgunCZUysalKTMaedaKet alA central role for JNK in obesity and insulin resistance. Nature (2002) 420:333–6.10.1038/nature01137

  • 116

    ArkanMCHevenerALGretenFRMaedaSLiZWLongJMet alIKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 11:191–8.10.1038/nm1185

  • 117

    YanXZhuMJXuWTongJFFordSPNathanielszPWet alUp-regulation of toll-like receptor 4/nuclear factor-kappaB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation. Endocrinology (2010) 151:380–7.10.1210/en.2009-0849

  • 118

    PoonKAlamMKaratayevOBarsonJRLeibowitzSF. Regulation of the orexigenic neuropeptide, enkephalin, by PPARdelta and fatty acids in neurons of the hypothalamus and forebrain. J Neurochem (2015) 135:918–31.10.1111/jnc.13298

  • 119

    DudeleAFischerCWElfvingBWegenerGWangTLundS. Chronic exposure to low doses of lipopolysaccharide and high-fat feeding increases body mass without affecting glucose tolerance in female rats. Physiol Rep (2015) 3:e12584.10.14814/phy2.12584

  • 120

    KandaHTateyaSTamoriYKotaniKHiasaKKitazawaRet alMCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 116:1494–505.10.1172/JCI26498

  • 121

    BanisadrGQueraud-LesauxFBoutterinMCPelapratDZalcBRosteneWet alDistribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem (2002) 81:257–69.10.1046/j.1471-4159.2002.00809.x

  • 122

    BanisadrGGosselinRDMechighelPRosteneWKitabgiPMelik ParsadaniantzS. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol (2005) 492:178–92.10.1002/cne.20729

  • 123

    WeisbergSPHunterDHuberRLemieuxJSlaymakerSVaddiKet alCCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2006) 116:115–24.10.1172/JCI24335C1

  • 124

    KangYSChaJJHyunYYChaDR. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments. Expert Opin Investig Drugs (2011) 20:745–56.10.1517/13543784.2011.575359

  • 125

    PruisMGLendvaiABloksVWZwierMVBallerJFde BruinAet alMaternal western diet primes non-alcoholic fatty liver disease in adult mouse offspring. Acta Physiol (Oxf) (2014) 210:215–27.10.1111/apha.12197

  • 126

    PoonKHoHTBarsonJRLeibowitzSF. Stimulatory role of the chemokine CCL2 in the migration and peptide expression of embryonic hypothalamic neurons. J Neurochem (2014) 131:509–20.10.1111/jnc.12827

  • 127

    PoonKAbramovaDHoHTLeibowitzSF. Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus. Neuroscience (2016) 324:407–19.10.1016/j.neuroscience.2016.03.017

  • 128

    MattsonSNRoebuckTM. Acquisition and retention of verbal and nonverbal information in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res (2002) 26:875–82.10.1111/j.1530-0277.2002.tb02617.x

  • 129

    RoszelEL. Central nervous system deficits in fetal alcohol spectrum disorder. Nurse Pract (2015) 40:24–33.10.1097/01.NPR.0000444650.10142.4f

  • 130

    MaierRV. Ethanol abuse and the trauma patient. Surg Infect (Larchmt) (2001) 2:133–41.10.1089/109629601750469456

  • 131

    LivyDJMillerEKMaierSEWestJR. Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol Teratol (2003) 25:447–58.10.1016/S0892-0362(03)00030-8

  • 132

    MargretCPLiCXChappellTDElbergerAJMattaSGWatersRS. Prenatal alcohol exposure delays the development of the cortical barrel field in neonatal rats. Exp Brain Res (2006) 172:1–13.10.1007/s00221-005-0319-0

  • 133

    GarroAJMcBethDLLimaVLieberCS. Ethanol consumption inhibits fetal DNA methylation in mice: implications for the fetal alcohol syndrome. Alcohol Clin Exp Res (1991) 15:395–8.10.1111/j.1530-0277.1991.tb00536.x

  • 134

    LiuYBalaramanYWangGNephewKPZhouFC. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics (2009) 4:500–11.10.4161/epi.4.7.9925

  • 135

    ChenYOzturkNCZhouFC. DNA methylation program in developing hippocampus and its alteration by alcohol. PLoS One (2013) 8:e60503.10.1371/journal.pone.0060503

  • 136

    MillerMW. Migration of cortical neurons is altered by gestational exposure to ethanol. Alcohol Clin Exp Res (1993) 17:304–14.10.1111/j.1530-0277.1993.tb00768.x

  • 137

    ChotroMGAriasC. Prenatal exposure to ethanol increases ethanol consumption: a conditioned response?Alcohol (2003) 30:19–28.10.1016/S0741-8329(03)00037-5

  • 138

    YoungentobSLGlendinningJI. Fetal ethanol exposure increases ethanol intake by making it smell and taste better. Proc Natl Acad Sci U S A (2009) 106:5359–64.10.1073/pnas.0809804106

  • 139

    AriasCChotroMG. Increased palatability of ethanol after prenatal ethanol exposure is mediated by the opioid system. Pharmacol Biochem Behav (2005) 82:434–42.10.1016/j.pbb.2005.09.015

  • 140

    SheaKMHewittAJOlmsteadMCBrienJFReynoldsJN. Maternal ethanol consumption by pregnant guinea pigs causes neurobehavioral deficits and increases ethanol preference in offspring. Behav Pharmacol (2012) 23:105–12.10.1097/FBP.0b013e32834ed866

  • 141

    NizhnikovMEMolinaJCVarlinskayaEISpearNE. Prenatal ethanol exposure increases ethanol reinforcement in neonatal rats. Alcohol Clin Exp Res (2006) 30:34–45.10.1111/j.1530-0277.2006.00009.x

  • 142

    PautassiRMNizhnikovMESpearNEMolinaJC. Prenatal ethanol exposure leads to greater ethanol-induced appetitive reinforcement. Alcohol (2012) 46:585–93.10.1016/j.alcohol.2012.05.004

  • 143

    BarsonJRLeibowitzSW. Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuropsychopharmacol Biol Psychiatry (2016) 65:321–9.10.1016/j.pnpbp.2015.02.006

  • 144

    AngelogianniPGianoulakisC. Prenatal exposure to ethanol alters the ontogeny of the beta-endorphin response to stress. Alcohol Clin Exp Res (1989) 13:564–71.10.1111/j.1530-0277.1989.tb00379.x

  • 145

    LeeSChoiIKangSRivierC. Role of various neurotransmitters in mediating the long-term endocrine consequences of prenatal alcohol exposure. Ann N Y Acad Sci (2008) 1144:176–88.10.1196/annals.1418.015

  • 146

    WilsonMEHandaRJ. Gonadotropin secretion in infantile rats exposed to ethanol in utero. Alcohol (1997) 14:497–501.10.1016/S0741-8329(97)00037-2

  • 147

    LugoJNJrMarinoMDGassJTWilsonMAKellySJ. Ethanol exposure during development reduces resident aggression and testosterone in rats. Physiol Behav (2006) 87:330–7.10.1016/j.physbeh.2005.10.005

  • 148

    GabrielKICunninghamCL. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcohol Clin Exp Res (2005) 29:75–80.10.1097/01.ALC.0000150014.79657.64

  • 149

    GlavasMMEllisLYuWKWeinbergJ. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone. Alcohol Clin Exp Res (2007) 31:1598–610.10.1111/j.1530-0277.2007.00460.x

  • 150

    LeeSRivierC. Long-term influence of an initial exposure to alcohol on the rat hypothalamic-pituitary axis. Alcohol Clin Exp Res (2003) 27:1463–70.10.1097/01.ALC.0000086065.06203.DD

  • 151

    GabrielKIYuCLOsbornJAWeinbergJ. Prenatal ethanol exposure alters sensitivity to the effects of corticotropin-releasing factor (CRF) on behavior in the elevated plus-maze. Psychoneuroendocrinology (2006) 31:1046–56.10.1016/j.psyneuen.2006.06.003

  • 152

    LeeSSchmidtDTildersFRivierC. Increased activity of the hypothalamic-pituitary-adrenal axis of rats exposed to alcohol in utero: role of altered pituitary and hypothalamic function. Mol Cell Neurosci (2000) 16:515–28.10.1006/mcne.2000.0890

  • 153

    ChoiIYLeeSRivierC. Novel role of adrenergic neurons in the brain stem in mediating the hypothalamic-pituitary axis hyperactivity caused by prenatal alcohol exposure. Neuroscience (2008) 155:888–901.10.1016/j.neuroscience.2008.04.081

  • 154

    WieczorekLFishEWO’Leary-MooreSKParnellSESulikKK. Hypothalamic-pituitary-adrenal axis and behavioral dysfunction following early binge-like prenatal alcohol exposure in mice. Alcohol (2015) 49:207–17.10.1016/j.alcohol.2015.01.005

  • 155

    VarlinskayaEITruxellEMSpearLP. Ethanol intake under social circumstances or alone in sprague-dawley rats: impact of age, sex, social activity, and social anxiety-like behavior. Alcohol Clin Exp Res (2015) 39:117–25.10.1111/acer.12604

  • 156

    LopezMFLaberK. Impact of social isolation and enriched environment during adolescence on voluntary ethanol intake and anxiety in C57BL/6J mice. Physiol Behav (2015) 148:151–6.10.1016/j.physbeh.2014.11.012

  • 157

    HeiligMKoobGF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 30:399–406.10.1016/j.tins.2007.06.006

  • 158

    ZorrillaEPLogripMLKoobGF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol (2014) 35:234–44.10.1016/j.yfrne.2014.01.001

  • 159

    BordnerKDeakT. Endogenous opioids as substrates for ethanol intake in the neonatal rat: the impact of prenatal ethanol exposure on the opioid family in the early postnatal period. Physiol Behav (2015) 148:100–10.10.1016/j.physbeh.2015.02.013

  • 160

    AbatePHernandez-FonsecaKReyes-GuzmanACBarbosa-LunaIGMendezM. Prenatal ethanol exposure alters met-enkephalin expression in brain regions related with reinforcement: possible mechanism for ethanol consumption in offspring. Behav Brain Res (2014) 274:194–204.10.1016/j.bbr.2014.08.022

  • 161

    JoyceEMIversenSD. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci Lett (1979) 14:207–12.10.1016/0304-3940(79)96149-4

  • 162

    KalivasPWWiderlovEStanleyDBreeseGPrangeAJJr. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther (1983) 227:229–37.

  • 163

    MorikawaHMorrisettRA. Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int Rev Neurobiol (2010) 91:235–88.10.1016/S0074-7742(10)91008-8

  • 164

    FabioMCVivasLMPautassiRM. Prenatal ethanol exposure alters ethanol-induced Fos immunoreactivity and dopaminergic activity in the mesocorticolimbic pathway of the adolescent brain. Neuroscience (2015) 301:221–34.10.1016/j.neuroscience.2015.06.003

  • 165

    JerlhagEEgeciogluELandgrenSSalomeNHeiligMMoecharsDet alRequirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A (2009) 106:11318–23.10.1073/pnas.0812809106

  • 166

    ZharkovskyTKaasikAJaakoKZharkovskyA. Neurodegeneration and production of the new cells in the dentate gyrus of juvenile rat hippocampus after a single administration of ethanol. Brain Res (2003) 978:115–23.10.1016/S0006-8993(03)02796-3

  • 167

    AbergEHofstetterCPOlsonLBreneS. Moderate ethanol consumption increases hippocampal cell proliferation and neurogenesis in the adult mouse. Int J Neuropsychopharmacol (2005) 8:557–67.10.1017/S1461145705005286

  • 168

    CullenCLBurneTHLavidisNAMoritzKM. Low dose prenatal ethanol exposure induces anxiety-like behaviour and alters dendritic morphology in the basolateral amygdala of rat offspring. PLoS One (2013) 8:e54924.10.1371/journal.pone.0054924

  • 169

    ZhouRWangSZhuX. Prenatal ethanol exposure attenuates GABAergic inhibition in basolateral amygdala leading to neuronal hyperexcitability and anxiety-like behavior of adult rat offspring. Neuroscience (2010) 170:749–57.10.1016/j.neuroscience.2010.07.055

  • 170

    ParkPHMillerRShuklaSD. Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. Biochem Biophys Res Commun (2003) 306:501–4.10.1016/S0006-291X(03)01040-4

  • 171

    MatoJMLuSC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology (2007) 45:1306–12.10.1002/hep.21650

  • 172

    ShuklaSDVelazquezJFrenchSWLuSCTickuMKZakhariS. Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res (2008) 32:1525–34.10.1111/j.1530-0277.2008.00729.x

  • 173

    Kaminen-AholaNAholaAMagaMMallittKAFaheyPCoxTCet alMaternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genet (2010) 6:e1000811.10.1371/journal.pgen.1000811

  • 174

    ZhangCRHoMFVegaMCBurneTHChongS. Prenatal ethanol exposure alters adult hippocampal VGLUT2 expression with concomitant changes in promoter DNA methylation, H3K4 trimethylation and miR-467b-5p levels. Epigenetics Chromatin (2015) 8:40.10.1186/s13072-015-0032-6

  • 175

    TilgHDiehlAM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 343:1467–76.10.1056/NEJM200011163432007

  • 176

    KubesPMehalWZ. Sterile inflammation in the liver. Gastroenterology (2012) 143:1158–72.10.1053/j.gastro.2012.09.008

  • 177

    QinLHeJHanesRNPluzarevOHongJSCrewsFT. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation (2008) 5:10.10.1186/1742-2094-5-10

  • 178

    BlancoAMPerez-AragoAFernandez-LizarbeSGuerriC. Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J Neurochem (2008) 106:625–39.10.1111/j.1471-4159.2008.05425.x

  • 179

    CippitelliAKarlssonCShawJLThorsellAGehlertDRHeiligM. Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats. Psychopharmacology (Berl) (2010) 211:367–75.10.1007/s00213-010-1891-y

  • 180

    RydellMCnattingiusSGranathFMagnussonCGalantiMR. Prenatal exposure to tobacco and future nicotine dependence: population-based cohort study. Br J Psychiatry (2012) 200:202–9.10.1192/bjp.bp.111.100123

  • 181

    O’CallaghanFVAl MamunAO’CallaghanMAlatiRNajmanJMWilliamsGMet alMaternal smoking during pregnancy predicts nicotine disorder (dependence or withdrawal) in young adults – a birth cohort study. Aust N Z J Public Health (2009) 33:371–7.10.1111/j.1753-6405.2009.00410.x

  • 182

    KleinLCStineMMPfaffDWVandenberghDJ. Laternal nicotine exposure increases nicotine preference in periadolescent male but not female C57B1/6J mice. Nicotine Tob Res (2003) 5:117–24.10.1080/1462220021000060446

  • 183

    MattaSGElbergerAJ. Combined exposure to nicotine and ethanol throughout full gestation results in enhanced acquisition of nicotine self-administration in young adult rat offspring. Psychopharmacology (Berl) (2007) 193:199–213.10.1007/s00213-007-0767-2

  • 184

    ChistyakovVPatkinaNTammimakiATalkaRSalminenOBelozertsevaIet alNicotine exposure throughout early development promotes nicotine self-administration in adolescent mice and induces long-lasting behavioural changes. Eur J Pharmacol (2010) 640:87–93.10.1016/j.ejphar.2010.04.044

  • 185

    SchneiderTBizarroLAshersonPJStolermanIP. Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology (Berl) (2012) 223:401–15.10.1007/s00213-012-2728-7

  • 186

    NewmanMBShytleRDSanbergPR. Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring. Behav Pharmacol (1999) 10:699–706.10.1097/00008877-199911000-00017

  • 187

    SlotkinTAChoHWhitmoreWL. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res Bull (1987) 18:601–11.10.1016/0361-9230(87)90130-4

  • 188

    BluhmALWeinsteinJSousaJA. Free radicals in tobacco smoke. Nature (1971) 229:500.10.1038/229500a0

  • 189

    DingYSZhangLJainRBJainNWangRYAshleyDLet alLevels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiol Biomarkers Prev (2008) 17:3366–71.10.1158/1055-9965.EPI-08-0320

  • 190

    XuDLiangGYanYEHeWWLiuYSChenLBet alNicotine-induced over-exposure to maternal glucocorticoid and activated glucocorticoid metabolism causes hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic alterations in fetal rats. Toxicol Lett (2012) 209:282–90.10.1016/j.toxlet.2012.01.006

  • 191

    GroveKLSekhonHSBroganRSKellerJASmithMSSpindelER. Chronic maternal nicotine exposure alters neuronal systems in the arcuate nucleus that regulate feeding behavior in the newborn rhesus macaque. J Clin Endocrinol Metab (2001) 86:5420–6.10.1210/jcem.86.11.8033

  • 192

    MorganAJHarrodSBLacyRTStanleyEMFadelJR. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. Drug Alcohol Depend (2013) 132:562–70.10.1016/j.drugalcdep.2013.04.003

  • 193

    MorgansternIBarsonJRLeibowitzSF. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev (2011) 4:163–73.10.2174/1874473711104030163

  • 194

    Toledo-RodriguezMLotfipourSLeonardGPerronMRicherLVeilletteSet alMaternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am J Med Genet B Neuropsychiatr Genet (2010) 153B:1350–4.10.1002/ajmg.b.31109

  • 195

    FuchikamiMMorinobuSSegawaMOkamotoYYamawakiSOzakiNet alDNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One (2011) 6:e23881.10.1371/journal.pone.0023881

  • 196

    ChenHParkerSLMattaSGSharpBM. Gestational nicotine exposure reduces nicotinic cholinergic receptor (nAChR) expression in dopaminergic brain regions of adolescent rats. Eur J Neurosci (2005) 22:380–8.10.1111/j.1460-9568.2005.04229.x

  • 197

    KaneVBFuYMattaSGSharpBM. Gestational nicotine exposure attenuates nicotine-stimulated dopamine release in the nucleus accumbens shell of adolescent Lewis rats. J Pharmacol Exp Ther (2004) 308:521–8.10.1124/jpet.103.059899

  • 198

    GoldABKellerABPerryDC. Prenatal exposure of rats to nicotine causes persistent alterations of nicotinic cholinergic receptors. Brain Res (2009) 1250:88–100.10.1016/j.brainres.2008.10.076

  • 199

    FungYKLauYS. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol Biochem Behav (1989) 33:1–6.10.1016/0091-3057(89)90419-X

  • 200

    WeiJWangJDwyerJBMangoldJCaoJLeslieFMet alGestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol (2011) 14:91–106.10.1017/S1461145710000416

  • 201

    HarrodSBLacyRTZhuJHughesBAPernaMKBrownRW. Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse (2011) 65:1382–92.10.1002/syn.20975

  • 202

    Abdel-RahmanADechkovskaiaAMSuttonJMChenWCGuanXKhanWAet alMaternal exposure of rats to nicotine via infusion during gestation produces neurobehavioral deficits and elevated expression of glial fibrillary acidic protein in the cerebellum and CA1 subfield in the offspring at puberty. Toxicology (2005) 209:245–61.10.1016/j.tox.2004.12.037

  • 203

    RoyTSSabherwalU. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol Teratol (1998) 20:465–73.10.1016/S0892-0362(97)00137-2

  • 204

    RoyTSSeidlerFJSlotkinTA. Prenatal nicotine exposure evokes alterations of cell structure in hippocampus and somatosensory cortex. J Pharmacol Exp Ther (2002) 300:124–33.10.1124/jpet.300.1.124

  • 205

    SantiagoSEHuffmanKJ. Postnatal effects of prenatal nicotine exposure on body weight, brain size and cortical connectivity in mice. Neurosci Res (2012) 73:282–91.10.1016/j.neures.2012.05.005

  • 206

    SlotkinTAOrband-MillerLQueenKLWhitmoreWLSeidlerFJ. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther (1987) 240:602–11.

  • 207

    AoyamaYToriumiKMouriAHattoriTUedaEShimatoAet alPrenatal nicotine exposure impairs the proliferation of neuronal progenitors, leading to fewer glutamatergic neurons in the medial prefrontal cortex. Neuropsychopharmacology (2016) 41:578–89.10.1038/npp.2015.186

  • 208

    BrydenDWBurtonACBarnettBRCohenVJHearnTNJonesEAet alPrenatal nicotine exposure impairs executive control signals in medial prefrontal cortex. Neuropsychopharmacology (2016) 41:716–25.10.1038/npp.2015.197

  • 209

    NavarroHASeidlerFJWhitmoreWLSlotkinTA. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J Pharmacol Exp Ther (1988) 244:940–4.

  • 210

    HaghighiASchwartzDHAbrahamowiczMLeonardGTPerronMRicherLet alPrenatal exposure to maternal cigarette smoking, amygdala volume, and fat intake in adolescence. JAMA Psychiatry (2013) 70:98–105.10.1001/archgenpsychiatry.2012.1101

  • 211

    XiaoDDasguptaCLiYHuangXZhangL. Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring. PLoS One (2014) 9:e108161.10.1371/journal.pone.0108161

  • 212

    MaNNicholsonCJWongMHollowayACHardyDB. Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase. Toxicol Appl Pharmacol (2014) 275:1–11.10.1016/j.taap.2013.12.010

  • 213

    TakiFAPanXLeeMHZhangB. Nicotine exposure and transgenerational impact: a prospective study on small regulatory microRNAs. Sci Rep (2014) 4:7513.10.1038/srep07513

  • 214

    RichmondRCSimpkinAJWoodwardGGauntTRLyttletonOMcArdleWLet alPrenatal exposure to maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC). Hum Mol Genet (2015) 24:2201–17.10.1093/hmg/ddu739

  • 215

    LeslieFM. Multigenerational epigenetic effects of nicotine on lung function. BMC Med (2013) 11:27.10.1186/1741-7015-11-27

  • 216

    SoporiMLKozakWSavageSMGengYSoszynskiDKlugerMJet alEffect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology (1998) 23:189–204.10.1016/S0306-4530(97)00076-0

  • 217

    KalraRSinghSPPena-PhilippidesJCLangleyRJRazani-BoroujerdiSSoporiML. Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clin Diagn Lab Immunol (2004) 11:563–8.10.1128/CDLI.11.3.563-568.2004

  • 218

    ChurgADaiJTaiHXieCWrightJL. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med (2002) 166:849–54.10.1164/rccm.200202-097OC

  • 219

    MohsenzadehYRahmaniACheraghiJPyraniMAsadollahiK. Prenatal exposure to nicotine in pregnant rat increased inflammatory marker in newborn rat. Mediators Inflamm (2014) 2014:274048.10.1155/2014/274048

Summary

Keywords

prenatal fat, prenatal ethanol, prenatal nicotine, inflammation, ingestive behavior

Citation

Poon K and Leibowitz SF (2016) Consumption of Substances of Abuse during Pregnancy Increases Consumption in Offspring: Possible Underlying Mechanisms. Front. Nutr. 3:11. doi: 10.3389/fnut.2016.00011

Received

30 January 2016

Accepted

04 April 2016

Published

20 April 2016

Volume

3 - 2016

Edited by

Patrick Christian Even, AgroParisTech, France

Reviewed by

Emmanuel N. Pothos, Tufts University School of Medicine, USA; Anna Aronis, The Hebrew University of Jerusalem, Israel

Updates

Copyright

© 2016 Poon and Leibowitz.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sarah F. Leibowitz,

Specialty section: This article was submitted to Clinical Nutrition, a section of the journal Frontiers in Nutrition

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Share on WeChat

Scan with WeChat to share this article

Article metrics